首页> 美国卫生研究院文献>Current Therapeutic Research Clinical and Experimental >Efficacy and Tolerability of Conventional Nimesulide Versus Beta-Cyclodextrin Nimesulide in Patients with Pain After Surgical Dental Extraction: A Multicenter Prospective Randomized Double-Blind Double-Dummy Study
【2h】

Efficacy and Tolerability of Conventional Nimesulide Versus Beta-Cyclodextrin Nimesulide in Patients with Pain After Surgical Dental Extraction: A Multicenter Prospective Randomized Double-Blind Double-Dummy Study

机译:常规尼美舒利与β-环糊精尼美舒利在手术拔牙后疼痛患者中的疗效和耐受性:多中心前瞻性随机双盲双假人研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Pain following extraction of an impacted third molar is widely used to assess analgesic efficacy, especially that of a single dose of a drug. The analgesic activity of conventional nimesulide (CN) has been documented in a variety of types of acute and chronic pain. Beta-cyclodextrin nimesulide (BN) is a new formulation in which nimesulide is included in a cyclodextrin molecule, which increases its solubility in water and its dilution rate, allowing extended, rapid absorption of the drug.>Objective: The aim of this study was to assess the efficacy and tolerability of a single dose of BN compared with CN in patients with pain following extraction of an impacted third molar.>Methods: This was a prospective, randomized, double-blind, double-dummy study conducted at 3 dentistry centers in Venezuela. The patients were randomized to 1 of 2 groups. One group received a single dose of BN (400-mg tablet, equivalent to 100 mg of nimesulide); the other group received a single dose of CN (100-mg tablet). Both groups also received a placebo. The efficacy variables were (1) pain intensity (PI), assessed on a visual analog scale (VAS) at the following times: 0, 5, 10, 15, 30, and 45 minutes and 1, 2, 4, 6, 8, 10, and 12 hours after drug administration; (2) time to first measurable difference in PI from baseline (PID) (PID ≥1 cm on the VAS; ie, the beginning of analgesic action); (3) maximum PID (max PID); (4) sum of PIDs in the 12-hour observation period; (5) pain relief (PR), as rated on a 5-point scale; (6) maximum PR; and (7) sum of the PR scores in the 12-hour observation period (ie, total PR). For the tolerability analysis, all adverse events (AEs) were to be recorded, and the investigators were to assess whether each AE was drug related.>Results: Seventy-two patients were enrolled in the study. Of these, 62 patients (40 women, 22 men; mean [SD] age, 20.1 [5.9] years) were assessed; 35 were treated with BN and 27 with CN. PI reduction was more rapid and greater in the BN group. The first measurable change in PI (PID ≥1 on the VAS) was reached within 5 minutes by 39% and 15% of the patients in the BN and CN groups, respectively, and within 10 minutes by 52% and 30% of the patients in the BN and CN groups, respectively. The max PID was reached <1 hour in 32% and 15% of patients in the BN and CN groups, respectively. No AEs were reported.>Conclusions: In this study population, both BN and CN were similarly effective in relieving pain after extraction of an impacted third molar, and both drugs were well tolerated. PI changes were statistically significantly more rapid and greater with BN than CN.
机译:>背景:提取受影响的第三磨牙后的疼痛被广泛用于评估止痛效果,尤其是单剂药物的止痛效果。常规尼美舒利(CN)的镇痛活性已在多种类型的急性和慢性疼痛中得到证明。 Beta-cyclodextrin尼美舒利(BN)是一种新制剂,其中尼美舒利包含在环糊精分子中,从而增加了其在水中的溶解度和稀释率,从而可以延长药物的吸收速度。>目的:这项研究的目的是评估单剂量BN与CN相比在拔除受影响的第三磨牙后疼痛患者中的疗效和耐受性。>方法:在委内瑞拉的3个牙科中心进行的双盲双假人研究。将患者随机分为2组中的1组。一组接受单剂量的BN(400毫克片剂,相当于100毫克尼美舒利);另一组接受单剂量的CN(100毫克片剂)。两组都还接受了安慰剂。功效变量为(1)疼痛强度(PI),在以下时间以视觉模拟量表(VAS)进行评估:0、5、10、15、30和45分钟,1、2、4、6、8给药后10小时和12小时; (2)从基线(PID)到PI首次可测量差异的时间(VAS上PID≥1 cm;即开始镇痛作用); (3)最大PID(max PID); (4)在12小时观察期内的PID总数; (5)疼痛缓解(PR),以5分制评分; (6)最高公关; (7)在12小时观察期内的PR分数总和(即总PR)。为了进行耐受性分析,应记录所有不良事件(AE),并由研究者评估每种AE是否与药物相关。>结果:该研究共纳入72名患者。在这些患者中,评估了62例患者(40名女性,22名男性;平均[SD]年龄,20.1 [5.9]岁)。 BN治疗35例,CN治疗27例。在BN组中,PI的减少更快且更大。 BN和CN组中分别有39%和15%的患者在5分钟内达到PI的首次可测量变化(VAS上PID≥1),而在10分钟内有52%和30%的患者达到了PI的首次可测量变化在BN和CN组中。 BN和CN组分别有32%和15%的患者的最大PID <1小时。 >结论:在该研究人群中,BN和CN在拔除受影响的第三磨牙后均能有效缓解疼痛,并且两种药物的耐受性均良好。与CN相比,BN的PI变化在统计学上显着更快,更大。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号